Cargando…

Chronic Hepatitis C-Related Cirrhosis Hospitalization Cost Analysis in Bulgaria

OBJECTIVE: HCV infection is a leading cause of chronic liver disease with long-term complications—extensive fibrosis, cirrhosis, and hepatocellular carcinoma. The objective of this study is to perform cost analysis of therapy of patients with chronic HCV-related cirrhosis hospitalized in the Univers...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dimitrova, Maria, Pavlov, Kaloyan, Mitov, Konstantin, Genov, Jordan, Petrova, Guenka Ivanova
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5545579/ https://www.ncbi.nlm.nih.gov/pubmed/28824914 http://dx.doi.org/10.3389/fmed.2017.00125

Ejemplares similares

Pilot Study on the Cost of Some Oncohematology Diseases in Bulgaria
por: Tachkov, Konstantin, et al.
Publicado: (2019)

New Epidemiological, Clinical and Economic Data for Patients With Acromegaly in Bulgaria
por: Kamusheva, Maria, et al.
Publicado: (2020)

Cost of outpatient hypertension pharmacotherapy: comparative study between Bulgaria and Serbia
por: Ivanova, Anna, et al.
Publicado: (2009)

Analysis of Healthcare Expenditures in Bulgaria
por: Mitkova, Zornitsa, et al.
Publicado: (2022)

Utilization, Cost, and Affordability of Antihypertensive Therapy in Bulgaria
por: Mitkova, Zornitsa, et al.
Publicado: (2021)

Humanistic and economic aspects of haemophilia treatment in Bulgaria. Comparison between two therapeutic approaches: prophylactic vs. on-demand treatment
por: Petrova, Guenka, et al.
Publicado: (2014)

Life expectancy and survival analysis of patients with diabetes compared to the non diabetic population in Bulgaria
por: Tachkov, Konstantin, et al.
Publicado: (2020)

Pharmacotherapeutic Patterns and Patients’ Access to Pharmacotherapy for Some Rare Diseases in Bulgaria – A Pilot Comparative Study
por: Kamusheva, Maria, et al.
Publicado: (2021)

Economic consequences of the vaccination against hepatitis A in the Bulgarian healthcare setting
por: Dimitrova, Maria, et al.
Publicado: (2014)

ISO 9001 certification for hospitals in Bulgaria: does it help service?
por: Stoimenova, Assena, et al.
Publicado: (2014)

Biosimilar Insulins and Their Impact on Prices and Utilization of Insulins in Bulgaria
por: Tachkov, Konstantin, et al.
Publicado: (2021)

Adherence to Acromegaly Treatment and Analysis of the Related Factors—A Real-World Study in Bulgaria
por: Kamusheva, Maria, et al.
Publicado: (2023)

Analysis of the Household and Health Care System Expenditures in Bulgaria
por: Mitkova, Zornitsa, et al.
Publicado: (2021)

Budget cap and pay-back model to control spending on medicines: A case study of Bulgaria
por: Mitkova, Zornitsa, et al.
Publicado: (2022)

Availability and reimbursement of biological products for severe asthma in Bulgaria
por: Milushewa, Petya, et al.
Publicado: (2020)

Treatment patterns, adherence to international guidelines, and financial mechanisms of the market access of advanced breast cancer therapy in Bulgaria
por: Karanyotova, Stephanie, et al.
Publicado: (2023)

Did the Introduction of Biosimilars Influence Their Prices and Utilization? The Case of Biologic Disease Modifying Antirheumatic Drugs (bDMARD) in Bulgaria
por: Tachkov, Konstantin, et al.
Publicado: (2021)

Study of Symptom Severity and Adherence to Therapy of Myelofibrosis Patients Treated with Ruxolitinib
por: Stoeva, Vera, et al.
Publicado: (2023)

Quality of Life and Cost Study of Rheumatoid Arthritis Therapy With Biological Medicines
por: Boyadzieva, Vladimira V., et al.
Publicado: (2018)

Incidence of virulence determinants in clinical Enterococcus faecalis and Enterococcus faecium isolates collected in Bulgaria
por: Strateva, Tanya, et al.
Publicado: (2016)

Evaluation of potentially inappropriate medication in older patients with cardiovascular diseases—STOPP/START-based study
por: Krustev, Tzvetan, et al.
Publicado: (2022)

Therapeutic Results and Survival of Patients with Myelofibrosis Treated with Ruxolitinib—A Real-Life Longitudinal Study
por: Stoeva, Vera, et al.
Publicado: (2023)

Аn affordability of statins therapy - comparative analysis between Ukraine and Bulgaria
por: Tkachova, Oksana, et al.
Publicado: (2019)

Regional health and social inequalities in Bulgaria
por: Tsanova, D, et al.
Publicado: (2023)

An Overview of the Reimbursement Decision-Making Processes in Bulgaria As a Reference Country for the Middle-Income European Countries
por: Kamusheva, Maria, et al.
Publicado: (2018)

Do Advanced Therapies Have a Future in the Low- and Middle-Income Countries - The Case of Bulgaria, Romania, and Poland
por: Kamusheva, Maria, et al.
Publicado: (2021)

Hepatitis C virus genotype analysis in patients with chronic hepatitis in North Eastern Bulgaria
por: Brady, Zarina, et al.
Publicado: (2019)

Sweet Basil between the Soul and the Table—Transformation of Traditional Knowledge on Ocimum basilicum L. in Bulgaria
por: Ivanova, Teodora, et al.
Publicado: (2023)

Advanced Glycation End Products as a Predictor of Diabetes Mellitus in Chronic Hepatitis C-Related Cirrhosis
por: Abdel-Razik, Ahmed, et al.
Publicado: (2020)

Assessment of the expectancy, seriousness and severity of adverse drug reactions reported for chronic obstructive pulmonary disease therapy
por: Petrova, Guenka, et al.
Publicado: (2017)

Assessment of the decreased productivity of patients with diabetes type 2 in the Clinical Endocrinological Center Sofia, Bulgaria
por: Plaveev, Ognian, et al.
Publicado: (2006)

Analysis of the Origin and Dissemination of HIV-1 Subtype C in Bulgaria
por: Alexiev, Ivailo, et al.
Publicado: (2022)

Efficacy and Safety of Sofosbuvir and Velpatasvir Combination for the Treatment of Chronic Hepatitis C in Patients With or Without Cirrhosis
por: Shah, Islam, et al.
Publicado: (2021)

Influence of Dietary Factors on Helicobacter pylori and CagA Seroprevalence in Bulgaria
por: Yordanov, Daniel, et al.
Publicado: (2017)

HCV transmission in high-risk communities in Bulgaria
por: Ganova-Raeva, Lilia, et al.
Publicado: (2019)

Increasing Hepatitis E Virus Seroprevalence in Domestic Pigs and Wild Boar in Bulgaria
por: Takova, Katerina, et al.
Publicado: (2020)

Emergence of VanB phenotype-vanA genotype Enterococcus faecium clinical isolate in Bulgaria
por: Strateva, Tanya, et al.
Publicado: (2014)

Metabolomic Signatures of Autoimmune Hepatitis in the Development of Cirrhosis
por: Li, Shan-shan, et al.
Publicado: (2021)

Tuberculosis in Adolescents in Bulgaria for a Three-Year Period: 2018–2020
por: Gabrovska, Natalia, et al.
Publicado: (2022)

Economic Burden of Cervical Cancer in Bulgaria
por: Lebanova, Hristina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dbptco28mbu99p8hblbvkrshe0